These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

514 related items for PubMed ID: 30572191

  • 1. Reversal of multidrug resistance in breast cancer cells by a combination of ursolic acid with doxorubicin.
    Zong L, Cheng G, Liu S, Pi Z, Liu Z, Song F.
    J Pharm Biomed Anal; 2019 Feb 20; 165():268-275. PubMed ID: 30572191
    [Abstract] [Full Text] [Related]

  • 2. Reversal of P-glycoprotein-mediated multidrug resistance is induced by saikosaponin D in breast cancer MCF-7/adriamycin cells.
    Li C, Guan X, Xue H, Wang P, Wang M, Gai X.
    Pathol Res Pract; 2017 Jul 20; 213(7):848-853. PubMed ID: 28554760
    [Abstract] [Full Text] [Related]

  • 3. Reversing Multidrug Resistance in Chemo-resistant Human Lung Adenocarcinoma (A549/DOX) Cells by Algerian Propolis Through Direct Inhibiting the P-gp Efflux-pump, G0/G1 Cell Cycle Arrest and Apoptosis Induction.
    Kebsa W, Lahouel M, Rouibah H, Zihlif M, Ahram M, Abu-Irmaileh B, Mustafa E, Al-Ameer HJ, Al Shhab M.
    Anticancer Agents Med Chem; 2018 Jul 20; 18(9):1330-1337. PubMed ID: 30088453
    [Abstract] [Full Text] [Related]

  • 4. Glabridin resensitizes p-glycoprotein-overexpressing multidrug-resistant cancer cells to conventional chemotherapeutic agents.
    Qian J, Xia M, Liu W, Li L, Yang J, Mei Y, Meng Q, Xie Y.
    Eur J Pharmacol; 2019 Jun 05; 852():231-243. PubMed ID: 30959046
    [Abstract] [Full Text] [Related]

  • 5. Targeting P-glycoprotein function, p53 and energy metabolism: Combination of metformin and 2-deoxyglucose reverses the multidrug resistance of MCF-7/Dox cells to doxorubicin.
    Xue C, Wang C, Sun Y, Meng Q, Liu Z, Huo X, Sun P, Sun H, Ma X, Ma X, Peng J, Liu K.
    Oncotarget; 2017 Jan 31; 8(5):8622-8632. PubMed ID: 28052008
    [Abstract] [Full Text] [Related]

  • 6. Enhanced effect of pH-sensitive mixed copolymer micelles for overcoming multidrug resistance of doxorubicin.
    Qiu L, Qiao M, Chen Q, Tian C, Long M, Wang M, Li Z, Hu W, Li G, Cheng L, Cheng L, Hu H, Zhao X, Chen D.
    Biomaterials; 2014 Dec 31; 35(37):9877-9887. PubMed ID: 25201738
    [Abstract] [Full Text] [Related]

  • 7. Targeting P-Glycoprotein: Nelfinavir Reverses Adriamycin Resistance in K562/ADR Cells.
    Liu W, Meng Q, Sun Y, Wang C, Huo X, Liu Z, Sun P, Sun H, Ma X, Liu K.
    Cell Physiol Biochem; 2018 Dec 31; 51(4):1616-1631. PubMed ID: 30497065
    [Abstract] [Full Text] [Related]

  • 8. Overcoming multidrug resistance by intracellular drug release and inhibiting p-glycoprotein efflux in breast cancer.
    Mao J, Qiu L, Ge L, Zhou J, Ji Q, Yang Y, Long M, Wang D, Teng L, Chen J.
    Biomed Pharmacother; 2021 Feb 31; 134():111108. PubMed ID: 33341670
    [Abstract] [Full Text] [Related]

  • 9. Effect of β-elemene on the kinetics of intracellular transport of d-luciferin potassium salt (ABC substrate) in doxorubicin-resistant breast cancer cells and the associated molecular mechanism.
    Tang CY, Zhu LX, Yu JD, Chen Z, Gu MC, Mu CF, Liu Q, Xiong Y.
    Eur J Pharm Sci; 2018 Jul 30; 120():20-29. PubMed ID: 29704644
    [Abstract] [Full Text] [Related]

  • 10. Investigations on the cell metabolomics basis of multidrug resistance from tumor cells by ultra-performance liquid chromatography-mass spectrometry.
    Zhang R, Zhuang X, Zong L, Liu S, Liu Z, Song F.
    Anal Bioanal Chem; 2016 Aug 30; 408(21):5843-5854. PubMed ID: 27379392
    [Abstract] [Full Text] [Related]

  • 11. Schisandrin A reverses doxorubicin-resistant human breast cancer cell line by the inhibition of P65 and Stat3 phosphorylation.
    Zhang ZL, Jiang QC, Wang SR.
    Breast Cancer; 2018 Mar 30; 25(2):233-242. PubMed ID: 29181822
    [Abstract] [Full Text] [Related]

  • 12. Alisol F 24 Acetate Enhances Chemosensitivity and Apoptosis of MCF-7/DOX Cells by Inhibiting P-Glycoprotein-Mediated Drug Efflux.
    Pan G, Li T, Zeng Q, Wang X, Zhu Y.
    Molecules; 2016 Feb 04; 21(2):. PubMed ID: 26861264
    [Abstract] [Full Text] [Related]

  • 13. Reversal of P-gp mediated multidrug resistance in-vitro and in-vivo by FG020318.
    Chen LM, Liang YJ, Ruan JW, Ding Y, Wang XW, Shi Z, Gu LQ, Yang XP, Fu LW.
    J Pharm Pharmacol; 2004 Aug 04; 56(8):1061-6. PubMed ID: 15285852
    [Abstract] [Full Text] [Related]

  • 14. Bipiperidinyl derivatives of 23-hydroxybetulinic acid reverse resistance of HepG2/ADM and MCF-7/ADR cells.
    Zhang DM, Li YJ, Shu C, Ruan ZX, Chen WM, Yiu A, Peng YH, Wang J, Lan P, Yao Z, Fung KP, Fu LW, Chen ZS, Ye WC.
    Anticancer Drugs; 2013 Jun 04; 24(5):441-54. PubMed ID: 23466650
    [Abstract] [Full Text] [Related]

  • 15. Reversal of P-glycoprotein-mediated multidrug resistance by CD44 antibody-targeted nanocomplexes for short hairpin RNA-encoding plasmid DNA delivery.
    Gu J, Fang X, Hao J, Sha X.
    Biomaterials; 2015 Mar 04; 45():99-114. PubMed ID: 25662500
    [Abstract] [Full Text] [Related]

  • 16. Reversing of multidrug resistance breast cancer by co-delivery of P-gp siRNA and doxorubicin via folic acid-modified core-shell nanomicelles.
    Wu Y, Zhang Y, Zhang W, Sun C, Wu J, Tang J.
    Colloids Surf B Biointerfaces; 2016 Feb 01; 138():60-9. PubMed ID: 26655793
    [Abstract] [Full Text] [Related]

  • 17. Exploration of 2-((Pyridin-4-ylmethyl)amino)nicotinamide Derivatives as Potent Reversal Agents against P-Glycoprotein-Mediated Multidrug Resistance.
    Qiu Q, Shi W, Li Z, Zhang B, Pan M, Cui J, Dai Y, Huang W, Qian H.
    J Med Chem; 2017 Apr 13; 60(7):2930-2943. PubMed ID: 28301155
    [Abstract] [Full Text] [Related]

  • 18. Synergistic effects of A-B-C-type amphiphilic copolymer on reversal of drug resistance in MCF-7/ADR breast carcinoma.
    Zhang L, Lu J, Qiu L.
    Int J Nanomedicine; 2016 Apr 13; 11():5205-5220. PubMed ID: 27785023
    [Abstract] [Full Text] [Related]

  • 19. Reversal effect of isotetrandrine, an isoquinoline alkaloid extracted from Caulis Mahoniae, on P-glycoprotein-mediated doxorubicin-resistance in human breast cancer (MCF-7/DOX) cells.
    Wang TX, Yang XH.
    Yao Xue Xue Bao; 2008 May 13; 43(5):461-6. PubMed ID: 18717331
    [Abstract] [Full Text] [Related]

  • 20. Resveratrol enhances chemosensitivity of doxorubicin in multidrug-resistant human breast cancer cells via increased cellular influx of doxorubicin.
    Kim TH, Shin YJ, Won AJ, Lee BM, Choi WS, Jung JH, Chung HY, Kim HS.
    Biochim Biophys Acta; 2014 Jan 13; 1840(1):615-25. PubMed ID: 24161697
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 26.